Adial Pharmaceuticals Inc... (ADIL)
0.75
-0.04 (-4.46%)
At close: Mar 03, 2025, 3:59 PM
0.73
-2.19%
After-hours: Mar 03, 2025, 05:32 PM EST
Adial Pharmaceuticals Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
| Cash & Equivalents | 2.83M | 4M | 6.06M | 4.4M | 6.78M | 3.87M | 18.25K | 87.99K | 162.38K |
| Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | 1.53M | -601.01K | -613.91K | 350K | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | n/a | 455K | 455K | n/a | 0.00 | n/a | n/a | 2.25K | 2.25K |
| Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 35.12K | n/a |
| Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 371.6K | 778.14K | 399.43K | 734.72K | 896.41K | 823.51K | 9K | 18.3K | 86.34K |
| Total Current Assets | 3.2M | 4.78M | 6.46M | 5.14M | 7.67M | 4.69M | 27.25K | 141.41K | 205.55K |
| Property-Plant & Equipment | n/a | 244.42K | 304.36K | n/a | n/a | n/a | n/a | n/a | n/a |
| Goodwill & Intangibles | 3.91K | 708.45K | 709.01K | 5.61K | 6.17K | 6.74K | 7.3K | 7.86K | 8.43K |
| Total Long-Term Assets | 1.54M | 952.87K | 1.01M | 355.61K | 6.17K | 6.74K | 7.3K | 10.11K | 10.68K |
| Total Assets | 4.74M | 5.73M | 7.47M | 5.49M | 7.68M | 4.7M | 34.55K | 151.53K | 216.22K |
| Account Payables | 127.39K | 276.41K | 286.19K | 648.74K | 190.2K | 99.67K | 342.08K | 20.01K | 37.48K |
| Deferred Revenue | n/a | n/a | 2.38M | n/a | n/a | n/a | n/a | n/a | n/a |
| Short-Term Debt | n/a | 113.66K | 49.59K | n/a | n/a | n/a | 689.26K | 234.25K | n/a |
| Other Current Liabilities | 525.69K | 1.4M | 2.39M | 856.64K | 348.85K | 158.3K | 752.00 | 752.00 | 15.6K |
| Total Current Liabilities | 653.08K | 1.79M | 2.72M | 1.51M | 539.05K | 257.97K | 1.03M | 255.02K | 53.08K |
| Long-Term Debt | n/a | 150.55K | 207.38K | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | 0.00 | 492K | 1.01M | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Liabilities | 437.00 | 665.44K | 1.24M | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Liabilities | 653.08K | 2.46M | 3.97M | 1.51M | 539.05K | 257.97K | 1.03M | 255.02K | 53.08K |
| Total Debt | n/a | 207.38K | 256.96K | n/a | n/a | n/a | 689.26K | 234.25K | n/a |
| Common Stock | 1.66K | 26.69K | 20.95K | 14.39K | 10.37K | 6.86K | 3.27K | 9.83M | 9.68M |
| Retained Earnings | -68.8M | -63.67M | -50.94M | -31.52M | -20.63M | -12.04M | -403.99K | -9.94M | -9.52M |
| Comprehensive Income | n/a | 0.00 | -0.00 | n/a | -0.00 | n/a | -596.83K | n/a | n/a |
| Shareholders Equity | 4.08M | 3.28M | 3.51M | 3.99M | 7.14M | 4.44M | -997.55K | -103.49K | 163.15K |
| Total Investments | 1.53M | -601.01K | -613.91K | 350K | n/a | n/a | n/a | n/a | n/a |